Tag: illumina

March 7, 2017

OPKO Subsidiary GenPath Women’s Health Announces Availability Of ClariTest

OPKO Health (NASDAQ:OPK) has announced GenPath Women's Health will begin offering ClariTest, a non-invasive prenatal test, to be performed initially...
January 18, 2017

Emerging Biotech Companies at Cantech 2017

Three emerging biotech companies took to the Cantech Investment Conference stage: ProMIS Neurosciences, RepliCel Life Sciences and Critical Outcome Technologies.
November 10, 2016

Illumina and Mayo Clinic Form Bioinformatics Relationship to Advance Genetic Disorder Testing

Illumina today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the...
September 8, 2016

Liquid Biopsy Market Size to Reach $5.96 Billion by 2030

A number of ongoing clinical trials are due to be completed between post 2017-18. It is expected that upon successful...
July 12, 2016

Helix Appoints Former Under Armour Chief Digital Officer and Co-Founder and CEO of MapMyFitness Robin Thurston as Chief Executive Officer

SAN CARLOS, Calif.–(BUSINESS WIRE)–Helix, the personal genomics company that brings DNA-powered partner apps and insights to consumers, today announced the...
July 7, 2016

Enzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc.

NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ) today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a...
June 16, 2016

Illumina Announces Initial Customer Orders for the Global Screening Array

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has signed deals with 12 customers for its new Infinium®...